Recently, the Injective protocol community overwhelmingly approved a governance proposal known as IIP-617, with a remarkable 99.89% support rate. This marks the beginning of a substantial deflationary phase for the INJ token economic model. Dubbed the "Supply Squeeze" proposal, its primary aim is to accelerate the reduction of INJ’s circulating supply by lowering new token issuance and strengthening the protocol’s buyback and burn mechanisms.
Governance Consensus
The Injective community has recently demonstrated strong consensus, with the governance proposal IIP-617 receiving near-unanimous approval. According to on-chain voting data, calculated based on staked voting power, the proposal secured 99.89% of votes in favor. This overwhelming majority reflects the community’s broad support for reforming the token economic model.
At its core, the proposal focuses on adjusting INJ’s issuance parameters while maintaining and optimizing the existing buyback and burn mechanisms. This combined approach aims to systematically reduce the token’s circulating supply.
To date, the Injective network’s burn mechanism has removed approximately 6.85 million INJ tokens from circulation. With the new rules in effect, this process is expected to accelerate even further.
Mechanism Analysis
Injective’s "Supply Squeeze" initiative employs a dual strategy: on one hand, it slows the rate of new token issuance; on the other, it continuously uses protocol-generated revenue to buy back and burn tokens from the market. This mechanism directly ties the protocol’s success to the scarcity of its token— as usage of the Injective ecosystem rises, protocol revenue increases, providing more funds for INJ buybacks and burns. This creates a positive feedback loop.
From a technical perspective, Injective is a Layer 1 blockchain focused on decentralized finance (DeFi) applications, with INJ as its native token serving multiple roles including staking, governance, and transaction fee payments. The new tokenomics model pushes INJ further toward being a deflationary asset. Over time, the reduction in circulating supply could have a structural impact on the token’s value.
Ecosystem
Despite facing market pressure on both INJ’s price and total value locked (TVL), Injective continues to attract institutional participation and technical collaborations in 2025. Cboe and Canary Capital have filed regulatory applications for staking-based Injective exchange-traded funds (ETFs). These funds are designed to hold and stake INJ through "approved staking platforms" to generate yield. On the validator network front, Deutsche Telekom MMS, the IT services subsidiary of Deutsche Telekom, joined as a network validator in February.
Recently, a South Korean university became the first academic institution to operate a validator node and conduct on-chain research on the network, highlighting Injective’s growing influence in academia.
AI and DeFi Integration
Injective is actively advancing the integration of artificial intelligence with decentralized finance. The network has enabled cross-chain communication channels with the Artificial Superintelligence Alliance (ASI). This partnership combines Injective’s DeFi capabilities with ASI’s advanced AI technology, opening up new possibilities for users and developers. With the activation of IBC channels, Injective users can now access ASI Alliance’s native tokens through decentralized applications and integrate sophisticated AI and autonomous agent functionalities into the DeFi ecosystem.
Meanwhile, Injective’s collaboration with OpenLedger has enabled verifiable autonomous AI actions, effectively bridging off-chain reasoning with on-chain DeFi execution. This integration allows AI not only to analyze market data but also to execute trading decisions directly within DeFi markets.
Price Performance Analysis
As of January 20, 2026, Gate market data shows that Injective (INJ) is trading at $4.80, with a 24-hour trading volume of approximately $925,600. INJ’s current market capitalization stands at around $481 million, representing a market share of 0.014%, with overall market sentiment remaining neutral.
In the short term, INJ’s price has risen 2.86% over the past 24 hours, demonstrating a degree of resilience amid broader market volatility. However, over a longer time frame, the token has declined 5.79% over the past 7 days, indicating that investor sentiment remains cautious and a clear short-term rebound has yet to materialize.
From a medium-term perspective, INJ has gained 1.65% over the past 30 days, showing relatively stable performance. However, in the long run, its price has dropped 76.75% over the past year. Compared to its all-time high of $52.62 recorded in March 2024, the current price reflects a significant pullback. This performance aligns closely with the broader market environment over the past year, which has seen altcoin valuations compress and liquidity tighten.
In terms of supply structure, both the current circulating and total supply of Injective stand at 100 million INJ, with the market cap and fully diluted valuation being equal and a 100% circulation rate. There is no maximum supply cap, making the tokenomics and governance mechanisms particularly critical for long-term value capture.
Based on Gate platform data, INJ’s current market status can be summarized as follows:
- Short-term price performance: Up 2.86% in 24 hours, but still in a pullback phase over 7 days, with clear short-term bull-bear competition
- Long-term market context: Down over 76% in the past year, still undergoing deep value correction
- Liquidity level: 24-hour trading volume below $1 million, indicating low market activity
- Supply structure: Fully circulating, with inflation and governance mechanisms playing a significant role in long-term price dynamics
- Market sentiment: Neutral, with no clear signs of renewed risk appetite
Overall, Injective (INJ) is currently experiencing a phase of range-bound price recovery within a low-valuation environment. Short-term price movements are primarily driven by overall market sentiment and liquidity changes, while medium- and long-term trends will depend on ecosystem activity, DeFi application growth, and ongoing optimization of the token economic model. Until a clear market reversal emerges, investors are advised to remain cautious and monitor changes in trading volume and on-chain fundamentals for dynamic assessment.
As of January 20, 2026, INJ is trading at approximately $4.80 on Gate. This Layer 1 blockchain, incubated by Binance and backed by Pantera Capital and Jump Crypto, is undergoing a fundamental transformation of its tokenomics. With traditional institutions like Deutsche Telekom and South Korean universities joining the validator network, and financial players such as Cboe showing interest in INJ staking ETFs, the Injective ecosystem is becoming increasingly diversified. On-chain governance voting has not only altered INJ’s issuance curve but also symbolizes a new level of maturity for DeFi projects—demonstrating that a community can rationally coordinate to adjust core economic parameters and pave the way for long-term growth.
